17 results about "Controlled substance" patented technology

A device includes a reservoir and a therapeutic substance located in the reservoir, where the device is an implantable therapeutic substance delivery device, and the device is configured to deliver the therapeutic substance to a recipient thereof by diffusion controlled release. In an exemplary embodiment, the device is also a cochlear implant.

A system and method are provided for remotely supervised preparation, verification, and controlled dispensing of medication doses at geographically distributed remote dispensing units. A recipient and a supervisor are authenticated. A real-time audiovisual session is established between the recipient and at least the supervisor, and additional authenticated participants may join without authority to actuate dose release. The system receives an electronic medication order and corresponding label data originating from an external clinical information system and authorizes preparation of doses at the remote dispensing unit based on the order. Prior to any release, verification data is presented to the supervisor. A controlled mechanical transfer mechanism is actuated to release a prepared dose to the recipient only after verification and affirmative authorization by an authenticated supervisor. The disclosed systems and methods are applicable to controlled substances and other medications requiring supervised dispensing.

A method, apparatus and computer program product are provided for a compiled standardized measure representative of a subset of prescription transactions associated with a controlled substance. The compiled standardized measures may be used in the prescription domain to notify prescribers of a patient's morphine milligram equivalent (MME) to reduce risks related to drug overdose, abuse, and the like. Historical prescription transactions may be accessed to identify prescriptions classified as an opioid or other controlled substance, and that may likely still be in a patient's possession based upon days supply, such that a daily MME may be calculated. Messaging is provided to the prescriber if the amount exceeds a maximum threshold, and the prescription can be changed accordingly.

Technologies for establishing an attestable proof of witness for a controlled substance transaction entry include a first computing device that establishes device communications with a second computing device. The first computing device executes an application associated with a software platform server. The device communications are established in response to a generation of a controlled substance transaction entry. A proof of witness is generated as a function of the established device communications and a controlled substance associated with the controlled substance transaction entry. The proof of witness is associated with the controlled substance transaction entry.

Technologies are disclosed for a hardware and software integrated inventory management system. A system receives a request from a client device of a user to access an inventory storage device storing one or more controlled substances. The system causes the inventory storage device to provide access to the client device. The system receives a hardware log generated by the inventory storage device, which provides one or more records relating to the access of the inventory storage device by the user. Each record providing information relating to one of the one or more controlled substances removed from the inventory storage device. An entry for a controlled substance log maintained by the system is generated for each record, and the system updates the controlled substance log with the generated entries.

A fulfillment system includes a platform for facilitating fulfillment of a prescription for a regulated product, such as a prescription drug, which also has a REMS, along with any applicable controlled substance scheduling requirements. The platform communicates with a computer network of a healthcare provider's office where a healthcare provider or other authorized prescriber issues a prescription for a patient. The platform also communicates with a pharmacy, such as a specialty pharmacy, for fulfillment of the prescription. The system electronically populates documents satisfying documentation requirements pertaining to a REMS, controlled substances regulations, prescriptions, other pertinent patient information, and / or other regulations or rules thereby eliminating paper and redundant documents and reducing the burden on the healthcare provider / healthcare system.

The following relates generally to facilitating delivery of prescription medication. In some embodiments, a pharmacy computer system: (i) receives a prescription, (ii) reviews the prescription, and (iii) sends the prescription to an intermediate cloud layer. The intermediate cloud layer may then determine a warehouse to send the prescription to based on at least one criteria. The at least one criteria may comprise at least one of: (i) a health insurance plan; (ii) whether the medication comprises a controlled substance; (iii) whether the medication must be refrigerated during shipping; (iv) a warehouse shipping address; or (v) a fulfillment cap of a warehouse.

The application belongs to the technical field of traditional Chinese medicine detection, and particularly relates to a method for determining seven active components in northern atractylodes medicinal materials. The method adjusts the concentrations of the control substances atractylone, atractylodin, beta-eudesmol, corynol, atractylodes lactone I, atractylodes lactone III and 5-hydroxymethyl furfural to 0.12 mg / mL, 0.21 mg / mL, 0.09 mg / mL, 0.13 mg / mL, 0.09 mg / mL, 0.06 mg / mL and 0.04 mg / mL respectively; and a single detection wavelength 203 nm is adopted. The method is simple, fast and quantitative, and can comprehensively, intuitively and more completely evaluate the efficacy of northern atractylodes.

Embodiments of the present disclosure include a network-enabled lockbox for securely dispensing a substance includes a wireless communication device, one or more sensors, and a rotating carousel containing one or more doses of the controlled substance. The carousel provides a dose of the substance during a preconfigured period of time. The one or more sensors detect one or more alert conditions. The wireless communications wirelessly communicate information between the network-enabled lockbox and a remote server. For example, the network-enabled lockbox for securely dispensing a substance includes an outer compartment, an interior frame inserted into the compartment and secured to the compartment, a top plate, a worm drive, an electric motor connected to the worm drive, control electronics for controlling the motor, a carousel connected to the worm drive, a plurality of sensors, and a communications subsystem for communicating data to a backend server.

The invention discloses a detection system and method for preventing ambulance of hemp essence medicine. The detection system comprises a terahertz detection module, an intelligent analysis module and a block chain evidence storage early warning module. The terahertz detection module performs non-contact spectral data acquisition at key nodes of the whole process of raw material storage, production line feeding, intermediate transfer, finished product storage and waste destruction; the intelligent analysis module performs preprocessing and feature extraction on the spectral data, and realizes substance identification and real-time quality monitoring based on a deep learning algorithm; and the block chain evidence storage early warning module carries out tampering-free on-chain evidence storage on the identification result and the related information, and triggers graded early warning and linkage disposal with production equipment when the identification is abnormal or the data deviation exceeds a threshold value. According to the invention, real-time, lossless and credible monitoring and tracing of the whole production process of the hemp extract medicine are realized, and the anti-fraud management and control capability is effectively improved.

This invention belongs to the field of empty bottle recycling technology for controlled substances, specifically relating to an anti-counterfeiting identification system for the recycling of empty bottles of controlled substances. This invention constructs random fingerprint data by extracting microstructural features such as microbubbles, microtextures, and microparticles from the bottle body, giving each empty bottle a unique physical identifier. This effectively avoids the problem of traditional identification codes being easily tampered with or copied. By integrating bottle cap damage features and sealing structure deformation features, it objectively characterizes whether the bottle has actually been opened, avoiding misjudgments caused by relying solely on appearance or markings. By extracting the distribution and diffusion morphology of residual particles on the inner wall and combining it with spatial path modeling, it can reconstruct the flow trajectory and deposition path of the drug within the bottle, thereby improving the ability to identify the actual use of the drug.

The present invention may comprise a bottle with a top including an interior cap with 12 vanes extending distally towards an axis shared with an outer cap. The plastic cap's vanes are resilient, engaging with a spray nozzle. The interior cap is free to slide or “wiggle” along the length of the outer cap but does not slide out of the outer cap due to four detaining bumps. The outer cap, with the interior cap installed, engages with four L-shaped protrusions such that the four bumps lock with the protrusions to lock the cap to the main body of the cylindrical spray bottle, preventing access to the spray nozzle actuator. This device is designed to deter access to harmful or controlled substances delivered by the spray nozzle by children.

The invention discloses an industry priority control new pollutant list identification method, which belongs to the technical field of priority pollutant identification, and comprises the following steps: (1) investigating industry production information, and constructing an industry information database; (2) performing non-targeted screening on the compounds, and constructing a compound database; (3) screening of characteristic pollutants: systematic screening and grouping of industrial characteristic pollutants are carried out on the compounds detected in the step (2) according to industrial practical application, supervised and controlled substances are directly designated as preferential pollutants, uncontrolled compounds are classified according to compound structures, and then subsequent classification is carried out; and (4) risk assessment and classification: according to a subsequent classification result in the step (3), assigning priority pollutants, dividing the priority pollutants into three classes, and performing risk management according to the classes to which the pollutants belong. According to the method, the problems of insufficient industry characteristics and low risk management and control practical operability existing in current industry priority management and control new pollutant identification are solved.

An apparatus and method for administering a substance to an animal or test subject. may include a device having a housing. The housing may include adjustable supports for adapting the device to many different test subject cages or enclosures. The housing may further have a nose-poke region containing a sensor and a substance delivery port. The sensor may determine when an animal or test subject is present within the nose-poke region. When a test subject is present within the nose-poke region, the device may signal for a chamber containing a ceramic disk to vaporize a substance within the chamber. The ceramic disk may vibrate at an ultrasonic frequency to vaporize the substance, which is then delivered to the nose-poke region via tubes connected to the substance delivery port. Excess substance vapor is removed using a constant-negative pressure vacuum attached to the device via a vacuum port.

This invention discloses a method, device, equipment, and medium for dynamic management of controlled substances. The method includes: determining the drug information, dispensing information, and patient identification information corresponding to the controlled substances to be dispensed; allowing the dispensing of the controlled substances after verification based on the drug information, dispensing information, and patient identification information; determining the drug usage information, drug retrieval information, and drug traceability information of the controlled substances to be dispensed; verifying the consistency of use of the controlled substances to be dispensed based on the drug information, dispensing information, patient identification information, drug usage information, drug retrieval information, and drug traceability information; and determining the management log of the controlled substances to be dispensed based on the drug information, dispensing information, patient identification information, dispensing compliance verification results, and usage consistency verification results. This achieves full traceability of drugs from dispensing to use and retrieval, meeting the stringent requirements of controlled substance management regulations.